In addition to no longer advertising or selling to U.S
The STEP 1 trial (published in the New England Journal of Medicine) documented mean weight reductions of 14.9% with once-weekly semaglutide 2.4 mg compared to 2.4% with placebo, with corresponding improvements in waist circumference of approximately 13.5 cm with semaglutide versus 4.1 cm with placebo after 68 weeks
Study: An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Compounded medications, including compounded semaglutide, are not FDA-approved and may be prescribed only when a licensed provider determines a clinically significant difference for an identified patient
Drugs like semaglutide and tirzepatide, sold as Ozempic, Wegovy, Mounjaro, and Zepbound, have been studied exhaustively for what they do to blood sugar, appetite, and weight
Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D (2003) Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane